667 related articles for article (PubMed ID: 16181235)
1. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
2. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
Yuen KC; Dunger DB
Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
[TBL] [Abstract][Full Text] [Related]
3. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
4. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
[TBL] [Abstract][Full Text] [Related]
5. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
Bülow B; Link K; Ahrén B; Nilsson AS; Erfurth EM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181
[TBL] [Abstract][Full Text] [Related]
6. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
7. Insulin sensitivity is impaired in adults with varying degrees of GH deficiency.
Murray RD; Shalet SM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):182-8. PubMed ID: 15670194
[TBL] [Abstract][Full Text] [Related]
8. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function.
Gillberg P; Bramnert M; Thorén M; Werner S; Johannsson G
Growth Horm IGF Res; 2001 Oct; 11(5):273-81. PubMed ID: 11735245
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
11. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
Amin R; Williams RM; Frystyk J; Umpleby M; Matthews D; Orskov H; Dalton RN; Dunger DB
Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188
[TBL] [Abstract][Full Text] [Related]
12. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
Yuen KC; Dunger DB
Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
[TBL] [Abstract][Full Text] [Related]
14. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
15. Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels.
Schmid C; Bianda T; Zwimpfer C; Zapf J; Wiesli P
Growth Horm IGF Res; 2005 Aug; 15(4):300-3. PubMed ID: 16054413
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deficient adults.
Krag MB; Rasmussen LM; Hansen TK; Frystyk J; Flyvbjerg A; Møller N; Jørgensen JO
Clin Endocrinol (Oxf); 2009 Sep; 71(3):363-8. PubMed ID: 19067726
[TBL] [Abstract][Full Text] [Related]
17. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
[TBL] [Abstract][Full Text] [Related]
18. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
[TBL] [Abstract][Full Text] [Related]
19. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
Albert SG; Haas MJ; Mooradian AD
Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
[TBL] [Abstract][Full Text] [Related]
20. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
